Media Update: New data at WMS 2023 reaffirm long-term efficacy of Nexviazyme® (avalglucosidase alfa) for the treatment of Pompe disease

Nitesh sinha October 06, 2023
https://ift.tt/KICSPgZ

from Sanofi - Aventis Groupe https://ift.tt/KNaeq0i
via IFTTT
Tags:
Nitesh sinha

Posted by: Nitesh sinha

Post a Comment

0 Comments

Please ,
Do not enter any kind of span link